- 1Department of Radiology, The Second Hospital of Jilin University, Changchun, China
- 2Department of Radiology, Jilin Province FAW General Hospital, Changchun, China
Bi-based nanomaterials, such as Bi2Se3, play an important part in biomedicine, such as photothermal therapy (PTT) and computed tomography (CT) imaging. Polyethylenimine (PEI)-modified ultrasmall Bi2Se3 nanodots were prepared using an ultrafast synthetic method at room temperature (25°C). Bi2Se3 nanodots exhibited superior CT imaging performance, and could be used as effective photothermal reagents owing to their broad absorption in the ultraviolet–visible–near infrared region. Under irradiation at 808 nm, PEI-Bi2Se3 nanodots exhibited excellent photothermal-conversion efficiency of up to 41.3%. Good biocompatibility and significant tumor-ablation capabilities were demonstrated in vitro and in vivo. These results revealed that PEI-Bi2Se3 nanodots are safe and a good nanotheranostic platform for CT imaging-guided PTT of cancer.
Introduction
The early diagnosis of cancer and “precision” medicine are major challenges for oncologists. Scientists need to develop multifunctional biocompatible nanotheranostic platforms that integrate diagnostic and therapeutic functions (Barreto et al., 2011; Ho et al., 2015; Chen et al., 2016). As a non-invasive method, phototherapy can alleviate the side-effects and suffering of treatment as compared with that using resection, chemotherapy, or radiotherapy (Cheng et al., 2014; Fan et al., 2017; Lei et al., 2018; Basak et al., 2019).
Photothermal therapy (PTT) has attracted significant research attention because it is highly efficient, minimally invasive, and controllable (Liu et al., 2019; Meng et al., 2020; Zhao et al., 2020). Recently, PTT agents, such as precious metals (e.g., Au, Pt, or Pd nanoparticles) (Yin et al., 2014; Tang et al., 2015; Zhu et al., 2017; Zhang et al., 2019), metal chalcogenides (e.g., CuS nanoparticles, Bi2S3 nanoparticles, Bi2Se3 nanosheets, MoS2 nanosheets, or MoSe2 nanosheets) (Liu et al., 2014; Yang et al., 2016; You et al., 2017; Huang et al., 2019; Wang et al., 2019), carbon derivatives (Bao et al., 2018; Ortega-Liebana et al., 2019), and polymeric nanoparticles (Han et al., 2018; Zhang et al., 2018), have aroused widespread research interest. In particular, Bi2Se3, with its broad near absorption in the infrared (NIR) region, excellent efficiency for photothermal conversion, good biocompatibility, and metabolizability, has been used as a PTT agent (Song et al., 2015; Cheng et al., 2016; Xie et al., 2017; Huang et al., 2019). Moreover, due to the high X-ray attenuation coefficient (5.74 cm2 g−1, 100 keV) and atomic number (Z = 83) of Bi than those of the extensively applied contrast agent iobitridol (X-ray attenuation coefficient of 1.94 cm2 g−1, 100 keV; Z = 53), Bi-based nanomaterials can be used as potential contrast agents for computed tomography (CT) (Lei et al., 2017). Thus, Bi2Se3 has been used widely as a powerful nanotheranostic agent in CT imaging-guided PTT of cancer. However, most reports have focused on the synthesis of Bi2Se3 nanosheets at high temperatures (Xiao et al., 2017; Xie et al., 2017). Nevertheless, the synthesis is more complicated, and a larger particle size is not conducive to biological metabolism. Only a few reports have focused on the ultrarapid synthesis of water-soluble ultrasmall Bi2Se3 nanodots at room temperature (25°C).
We report a facile room-temperature method for synthesizing ultrasmall polyethylenimine-decorated Bi2Se3 (PEI-Bi2Se3) nanodots for CT imaging-guided PTT of cancer in vitro and in vivo. Compared with strategies reported previously, the rapid synthesis of PEI-Bi2Se3 nanodots may improve the efficiency of the synthesis and prevent further surface modification. Furthermore, the raw materials are inexpensive, and the organic solvents are nontoxic and environmentally friendly, thereby making the process suitable for future production at a large scale.
The synthesized nanodots exhibited excellent absorption properties and the efficiency of photothermal conversion was high under laser irradiation at 808 nm. Moreover, the outstanding CT imaging and photothermal-ablation capacity observed in vitro and in vivo, and non-significant long-term toxicity observed in vivo, revealed that PEI-Bi2Se3 nanodots could achieve CT imaging-guided PTT of cancer. Hence, PEI-Bi2Se3 nanodots could be powerful and safe nanotheranostic agents in cancer therapy.
Results and Discussion
The Synthesis and Characterization of PEI-Bi2Se3 Nanodots
A novel NIR light-responsive nanotheranostic platform based on PEI-Bi2Se3 nanodots for CT imaging-guided PTT of cancer was fabricated (Scheme 1). Under the protection of an inert-gas atmosphere and ice-water bath, Se powder was reduced by NaBH4 under magnetic stirring at room temperature (25°C) to obtain NaHSe solution (Se2− precursor solution). An appropriate amount of the Se2− precursor solution was transferred rapidly to a mixed solution of ethylene glycol and water containing Bi(NO3)3·5H2O and PEI. The reaction solution turned black rapidly, indicating that the reaction was ultra-facile and efficient (within 1 min). In the Experimental section in Supplementary Material, the experimental details are presented. Moreover, Bi2Se3 nanodots had promising potential for CT imaging-guided PTT of cancer owing to an efficient photothermal performance, strong absorption in the NIR region, and the high X-ray attenuation coefficient of Bi3+.
A transmission electron microscopy (TEM) image of the obtained PEI-Bi2Se3 nanodots is shown in Figure 1A. A clear lattice fringe with a distance of 0.304 nm can be seen on the high-resolution TEM image (Figure 1B), which can be attributed to the (015) planes of Bi2Se3. Furthermore, the prepared PEI-Bi2Se3 nanodots, as uniform spheres with relatively narrow size distribution, had a mean diameter of 3.56 nm (Figure 1C). The X-ray diffraction (XRD) patterns of the prepared PEI-Bi2Se3 nanodots are shown in Supplementary Figure S1. All the characteristic XRD peaks matched well with the standard hexagonal phase of Bi2Se3 (Joint Committee on Powder Diffraction Standards = 33-0214). Moreover, PEI-Bi2Se3 nanodots could maintain good dispersity in various solutions, such as Dulbecco’s modified Eagle’s medium, phosphate-buffered saline (PBS), NaCl, and water, for several months (Supplementary Figure S2), indicating that the PEI modification was beneficial for improving the stability of PEI-Bi2Se3 nanodots.
Photothermal Performance of PEI-Bi2Se3 Nanodots in vitro
PEI-Bi2Se3 nanodots showed a broad ultraviolet–visible–NIR (UV–Vis–NIR) absorption spectrum ranging from 500 to 1,100 nm (Figure 2A). As the concentration of Bi3+ increased, the absorption intensity of PEI-Bi2Se3 nanodots was enhanced, and the colorless solution turned dark black (Supplementary Figure S3). Absorbance at 808 nm increased linearly (Supplementary Figure S4), which suggested that PEI-Bi2Se3 nanodots exhibited good dispersibility in water, and could be excellent photothermal agents for PTT. To investigate the photothermal performance, pure water (control) and aqueous solutions of PEI-Bi2Se3 nanodots (25, 50, 100, 200 μg/ml) were exposed to a NIR laser (808 nm, 1.0 W cm−2) for 10 min. The temperatures of the different PEI-Bi2Se3 nanodot solutions increased rapidly, exhibiting noticeable concentration- and irradiation time-dependent behavior (Figure 2B). This finding indicated that the temperature of the PEI-Bi2Se3 solution could reach up to 70.1°C at a concentration of 200 μg ml−1 (1.0 W cm−2, 10 min), which is highly effective for killing tumor cells via hyperthermia. In contrast, under identical experimental conditions, the temperature of pure water increased by up to 8.4°C (Figure 2C). The IR thermal images of pure water and aqueous solution of PEI-Bi2Se3 nanodots (200 μg ml−1) after a certain duration of irradiation are shown in Figure 2D. The temperature of the PEI-Bi2Se3 aqueous solution (200 μg ml−1) increased rapidly with an increase in the irradiation duration using a laser at 808 nm whereas, under identical conditions, the temperature of pure water increased slowly.
FIGURE 2. (A) UV–Vis–NIR absorption spectra of PEI-Bi2Se3 nanodots in water with different concentrations of Bi+3. (B) Plot of temperature increase of pure water and aqueous solutions of PEI-Bi2Se3 nanodots of different concentrations upon exposure to a NIR laser at 808 nm (1.0 Wcm−2) as a function of irradiation duration. The temperature was measured every 10 s using a thermocouple microprobe. (C) Plot of temperature change (ΔT) over a period of 600 s vs. the concentration of PEI-Bi2Se3 nanodots. (D) IR thermal images of an aqueous solution of PEI-Bi2Se3 nanodots (200 μg ml−1) and pure water after irradiation for 10 min (808 nm, 1.0 W cm−2). (E) Photothermal response of an aqueous solution of PEI-Bi2Se3 nanodots (200 μg ml−1) after irradiation for 600 s with an NIR laser (808 nm, 1.0 W cm−2). Subsequently, the laser was turned off. (F) Linear time data vs. −lnθ obtained after a cooling period of (E).
PEI-Bi2Se3 nanodots could therefore convert NIR energy into thermal energy rapidly and efficiently, and act as potential photothermal agents during PTT. In particular, the efficiency of photothermal conversion of PEI-Bi2Se3 nanodots was up to 41.3% (Figures 2E,F), which is much higher than that of currently reported photothermal agents, such as PVP-Bi nanodots (∼30%) (Lei et al., 2017), Bi2Se3 nanosheets (∼33%) (Xie et al., 2017), and Cu2−xSe nanocrystals (∼22%) (Hessel et al., 2011). Photostability is another prerequisite for evaluating the performance of photothermal agents during PTT. After irradiation of the aqueous solution of PEI-Bi2Se3 nanodots (200 μg ml−1) using a continuous-wave NIR laser at 808 nm for 1 h (1.0 W cm−2), the color of the solution, UV–Vis–NIR spectrum, and morphology exhibited no distinct changes (Supplementary Figures S5, S6). Hence, PEI-Bi2Se3 nanodots possessed satisfactory photothermal stability. All the results shown above (excellent photothermal effect and good photostability) highlighted the potential of PEI-Bi2Se3 nanodots as suitable agents for PTT of cancer.
Studies on Cytotoxicity and Photothermal Ablation of Tumor Cells
Evaluation of the cytotoxicity of PEI-Bi2Se3 nanodots is important. The cytotoxicity of PEI-Bi2Se3 nanodots was tested by the Cell Counting Kit-8 assay. Even at a high concentration of PEI-Bi2Se3 nanodots (200 μg ml−1), the viability of A549 cells was 96 and 92% after incubation for 24 h (red bars) and 48 h (green bars), respectively (Figure 3A). These results indicated that PEI-Bi2Se3 nanodots exhibited no distinct toxicity towards A549 cells.
FIGURE 3. (A) Viability of A549 cells incubated with PEI-Bi2Se3 nanodots (0–200 μg ml−1) for 24 and 48 h (B) IR thermal images of A549 cells in a 96-well plate incubated with PEI-Bi2Se3 nanodots after irradiation for 10 min (808 nm, 1.0 W cm−2). (C) Fluorescence images of A549 cells stained with calcein-AM (live cells, green) and PI (dead cells, red) after various treatments. Scale bar = 200 μm.
Because of the outstanding photothermal performance of PEI-Bi2Se3 nanodots, we investigated their photothermal effects against tumor cells. The IR thermal images of A549 cells incubated with PEI-Bi2Se3 nanodots in a 96-well plate are shown in Figure 3B. Notably, the temperature could increase up to 53.8°C under irradiation at 808 nm (1.0 W cm−2) after addition of PEI-Bi2Se3 nanodots to the culture. Cancer cells are sensitive to heat, and can be killed effectively at >42°C. To identify further the anti-cancer effect of PEI-Bi2Se3 nanodots on A549 cells, live and dead cells were imaged using a fluorescence microscope after staining with calcein acetoxymethyl ester (green fluorescence) and propidium iodide (red fluorescence), respectively. In the control groups, notable cytotoxicity was not observed (PBS, PEI-Bi2Se3 nanodots only, laser only), whereas almost no living cells were observed in the PEI-Bi2Se3 + laser group (Figure 3C). These results suggested that the as-synthesized PEI-Bi2Se3 nanodots with low cytotoxicity would produce satisfactory results upon in vivo cancer treatment. In addition, endocytosis pathways were determined in order to identify the uptake mechanism of extracellular PEI-Bi2Se3 nanodots. The cellular uptake of PEI-Bi2Se3 was evaluated by monitoring the fluorescence of FITC in the A549 cells at various incubation times (1, 3, and 6 h). As shown in Supplementary Figure S7, green fluorescence of FITC was observed after 1 h incubation with FITC-labeled PEI-Bi2Se3. The signals increase obviously with incubation time, demonstrating efficient internalization of PEI-Bi2Se3 by cancer cells.
CT Imaging in vitro and in vivo
High resolution, easy manipulation, and high penetrability make CT imaging an important part of medical diagnoses (Lee et al., 2013; Du et al., 2020). Bi element with its large atomic number and high electron density has promising capacity for X-ray attenuation (Kinsella et al., 2011; Li et al., 2016). The X-ray absorption coefficient and iobitridol were compared to evaluate the in vitro CT imaging capability of PEI-Bi2Se3 nanodots. The latter exhibited a much higher CT density than that of iobitridol at equivalent concentrations (Figure 4A), whereas the Hounsfield unit (HU) values of both contrast agents exhibited a typical linear dependence on the concentration (Figure 4B). Compared with the curve for iobitridol, the curve for PEI-Bi2Se3 nanodots had a steeper slope. Hence, the as-synthesized PEI-Bi2Se3 nanodots had superior ability in CT imaging and were effective contrast agents.
FIGURE 4. (A) In vitro CT images of iobitridol and PEI-Bi2Se3 nanodots at different concentrations. (B) Concentration-dependent CT signals of iobitridol (black line) and PEI-Bi2Se3 nanodots (red line) in vitro. (C) Time-dependent CT imaging of tumor-bearing mice before and after intravenous injection of PEI-Bi2Se3 nanodots. (D) CT signal intensities of the tumor area at different times.
Inspired by the satisfactory CT effect in vitro, we assessed the feasibility of using PEI-Bi2Se3 nanodots as CT contrast agents in vivo. Time-dependent CT imaging was undertaken after tumor-bearing mice were injected (i.v.) with PEI-Bi2Se3 nanodots (Bi concentration = 30 mM, 150 μL). At 0 h–1 h after injection, the CT density at the tumor site brightened gradually (Figure 4C), which was caused by passive accumulation of PEI-Bi2Se3 nanodots at the tumor site through the enhanced permeability and retention effect. Thereafter, the density decreased because some PEI-Bi2Se3 nanodots had metabolized. The mean HU value increased from 40.2 HU (pre-injection) to 40.7 HU (0.5 h) and 51.6 HU (1 h) and decreased gradually from 49.4 HU (2 h) to 46.1 HU (24 h) at the tumor site (Figure 4D). These results demonstrated that PEI-Bi2Se3 nanodots could serve as promising in vivo CT contrast agents for the accurate diagnosis of cancer.
Photothermal Effect, Photothermal Therapy, and Long-Term Toxicity of PEI-Bi2Se3 Nanodots in vivo
Based on the good properties of PEI-Bi2Se3 nanodots at tumor sites (i.e., excellent in vitro photothermal effect, satisfactory CT imaging effect, and outstanding passive targeted accumulation), we studied the feasibility of CT imaging-guided PTT of cancer in vivo. PEI-Bi2Se3 nanodots (Bi concentration = 20 mg kg−1) were injected (i.v.) into tumor-bearing mice. Obvious enhancement was observed 1 h after injection, so the tumor was irradiated using a laser at 808 nm (1.0 W cm−2) 1-h later, and the photothermal effect in vivo was monitored by an IR thermal camera. The temperature at the tumor site in the treatment group increased rapidly as the duration of irradiation increased (Figure 5A) but the temperature at the tumor site did not show a significant change compared with that in the control group. The corresponding curve detailing temperature variation is shown as Figure 5B. After 10 min of NIR irradiation (808 nm, 1.0 W cm−2), in the presence of PEI-Bi2Se3 nanodots, the temperature at the tumor sites was as high as 51.1°C whereas, in the control group, a minor increase in temperature was observed. Hence, PEI-Bi2Se3 nanodots could serve as excellent photothermal agents for in vivo tumor ablation: they could kill cancer cells and inhibit their continued diffusion.
FIGURE 5. (A) IR thermal images and (B) corresponding curve showing the temperature variation of tumor-bearing mice injected (i.v.) with PBS (control) or PEI-Bi2Se3 nanodots, followed by irradiation with a laser at 808 nm for 10 min (C) Bodyweight of mice and (D) curves showing relative tumor growth in different groups after various treatments. (E) Mean tumor weight of each group after various treatments. (F) Photographs of tumors of each group and (G) H&E staining of tumor slides collected from different groups. All scale bars = 100 µm.
A tumor model was established by injecting (s.c.) U14 cells into the left axilla of female Kunming mice. Once the tumors had grown to ∼100 mm3, mice were used for experimentation. The mice bearing the U14 cells were divided randomly into four groups of six: 1) control; 2) laser only; 3) PEI-Bi2Se3 nanodots; 4) PEI-Bi2Se3 nanodots + laser. The tumors in mice were irradiated (808 nm) 1 h after injection of PEI-Bi2Se3 nanodots. The bodyweight and tumor volume of mice were measured every 2 days to evaluate therapeutic efficacy. After various treatments, the bodyweight of mice showed a steady increase (Figure 5C), thereby indicating that PEI-Bi2Se3 nanodots did not produce toxic side-effects during PTT. The tumor volume of each mouse was measured using a Vernier caliper, and plotted as a function of the relative tumor volume and treatment duration (Figure 5D). The average weights of excised tumors are shown in Figure 5E, and representative tumor photographs of each group are shown in Figure 5F. Compared with groups 1–3, the growth of tumors in group 4 was inhibited significantly after 14 days of PTT. In addition, hematoxylin and eosin (H&E) staining revealed no appreciable damage in groups 1–3; simultaneously, severe shrinkage and discrete cancer cells were observed clearly in group 4 (Figure 5G). Taken together, these results demonstrated that PEI-Bi2Se3 nanodots possessed potential as ideal and safe photothermal agents for cancer treatment.
The potential long-term toxicity of PEI-Bi2Se3 nanodots in vivo was also investigated. Thirty days after injection, pathological samples of major organs (heart, lungs, liver, spleen, kidneys) from control mice and treated mice were obtained. H&E staining (Figure 6) revealed no distinct tissue damage or inflammatory lesions in any major organ. Moreover, there were no abnormal signs in treated mice during the entire observation period. These results confirmed that PEI-Bi2Se3 nanodots were not significantly toxic in vivo.
FIGURE 6. H&E staining of major organs (heart, liver, spleen, lungs, and kidneys) of mice 30 days after injection of PEI-Bi2Se3 nanodots. All scale bars = 100 µm.
Conclusion
Ultrasmall PEI-Bi2Se3 nanodots were fabricated via an ultrafast, facile, and environmentally friendly method. The obtained PEI-Bi2Se3 nanodots could ensure good contrast enhancement owing to their high X-ray attenuation coefficient, and showed good photothermal killing effects in vitro and in vivo owing to considerable photothermal-conversion effects. Moreover, PEI-Bi2Se3 nanodots possessed negligible long-term toxicity in vivo. Therefore, we believe that the as-synthesized PEI-Bi2Se3 nanodots are useful theranostic agents for CT-imaging-guided PTT of cancer.
Data Availability Statement
The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding author.
Ethics Statement
The animal study was reviewed and approved by the Laboratory Animal Center of Jilin University.
Author Contributions
PZ contributed to the conception and design of the study. XL provided the database for mice experiments. LW contributed to the data analysis of the revised manuscript. XL and XC provided the testing instruments and site. PZ wrote the first draft of the manuscript. XC and QY revised and edited the manuscript. All authors contributed to the manuscript and approved the submitted version.
Funding
This work was supported by the Bethune Science Support Program of Jilin University (No. 2018B33), Program of Science and Technology Development Plan of Jilin Province of China (No. 20190201218JC), the Health Special Project of Jilin Province Department of Finance (Nos. 2019SCE7025, 2020SCZT088).
Conflict of Interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary Material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fphar.2021.795012/full#supplementary-material
References
Bao, X., Yuan, Y., Chen, J. Q., Zhang, B. H., Li, D., Zhou, D., et al. (2018). In Vivo Theranostics with Near-Infrared-Emitting Carbon Dots – Highly Efficient Photothermal Therapy Based on Passive Targeting after Intravenous Administration. Light-sci. Appl. 7, 11. doi:10.1038/s41377-018-0090-1
Barreto, J. A., O'Malley, W., Kubeil, M., Graham, B., Stephan, H., and Spiccia, L. (2011). Nanomaterials: Applications in Cancer Imaging and Therapy. Adv. Mater. 23 (12), H18–H40. doi:10.1002/adma.201100140
Basak, K., Luís Deán-Ben, X., Gottschalk, S., Reiss, M., and Razansky, D. (2019). Non-invasive Determination of Murine Placental and Foetal Functional Parameters with Multispectral Optoacoustic Tomography. Light Sci. Appl. 8, 71. doi:10.1038/s41377-019-0181-7
Chen, G., Roy, I., Yang, C., and Prasad, P. N. (2016). Nanochemistry and Nanomedicine for Nanoparticle-Based Diagnostics and Therapy. Chem. Rev. 116 (5), 2826–2885. doi:10.1021/acs.chemrev.5b00148
Cheng, L., Shen, S., Shi, S., Yi, Y., Wang, X., Song, G., et al. (2016). FeSe2-Decorated Bi2Se3 Nanosheets Fabricated via Cation Exchange for Chelator-free 64Cu-Labeling and Multimodal Image-Guided Photothermal-Radiation Therapy. Adv. Funct. Mater. 26 (13), 2185–2197. doi:10.1002/adfm.201504810
Cheng, L., Wang, C., Feng, L., Yang, K., and Liu, Z. (2014). Functional Nanomaterials for Phototherapies of Cancer. Chem. Rev. 114 (21), 10869–10939. doi:10.1021/cr400532z
Du, K., Lei, P., Dong, L., Zhang, M., Gao, X., Yao, S., et al. (2020). In Situ decorating of Ultrasmall Ag2Se on Upconversion Nanoparticles as Novel Nanotheranostic Agent for Multimodal Imaging-Guided Cancer Photothermal Therapy. Appl. Mater. Today 18, 100497. doi:10.1016/j.apmt.2019.100497
Fan, W., Yung, B., Huang, P., and Chen, X. (2017). Nanotechnology for Multimodal Synergistic Cancer Therapy. Chem. Rev. 117 (22), 13566–13638. doi:10.1021/acs.chemrev.7b00258
Han, Y., Chen, Z., Zhao, H., Zha, Z., Ke, W., Wang, Y., et al. (2018). Oxygen-independent Combined Photothermal/Photodynamic Therapy Delivered by Tumor Acidity-Responsive Polymeric Micelles. J. Control Release 284, 15–25. doi:10.1016/j.jconrel.2018.06.012
Hessel, C. M., Pattani, V. P., Rasch, M., Panthani, M. G., Koo, B., Tunnell, J. W., et al. (2011). Copper Selenide Nanocrystals for Photothermal Therapy. Nano Lett. 11 (6), 2560–2566. doi:10.1021/nl201400z
Ho, D. A., Wang, C. H. K., and Chow, E. K. H. (2015). Nanodiamonds: the Intersection of Nanotechnology, Drug Development, and Personalized Medicine. Sci. Adv. 1 (7), 14. doi:10.1126/sciadv.1500439
Huang, Y., Huang, J., Jiang, M., and Zeng, S. (2019). NIR-triggered Theranostic Bi2S3 Light Transducer for On-Demand NO Release and Synergistic Gas/Photothermal Combination Therapy of Tumors. ACS Appl. Bio Mater. 2 (11), 4769–4776. doi:10.1021/acsabm.9b00522
Kinsella, J. M., Jimenez, R. E., Karmali, P. P., Rush, A. M., Kotamraju, V. R., Gianneschi, N. C., et al. (2011). X-Ray Computed Tomography Imaging of Breast Cancer by Using Targeted Peptide-Labeled Bismuth Sulfide Nanoparticles. Angew. Chem. Int. Ed. Engl. 50 (51), 12308–12311. doi:10.1002/anie.201104507
Lee, N., Choi, S. H., and Hyeon, T. (2013). Nano-sized CT Contrast Agents. Adv. Mater. 25 (19), 2641–2660. doi:10.1002/adma.201300081
Lei, P., An, R., Zhang, P., Yao, S., Song, S., Dong, L., et al. (2017). Ultrafast Synthesis of Ultrasmall Poly(Vinylpyrrolidone)-Protected Bismuth Nanodots as a Multifunctional Theranostic Agent for In Vivo Dual-Modal CT/Photothermal-imaging-guided Photothermal Therapy. Adv. Funct. Mater. 27 (35), 1702018. doi:10.1002/adfm.201702018
Lei, P., An, R., Zheng, X., Zhang, P., Du, K., Zhang, M., et al. (2018). Ultrafast Synthesis of Ultrasmall Polyethylenimine-Protected AgBiS2 Nanodots by "rookie Method" for In Vivo Dual-Modal CT/PA Imaging and Simultaneous Photothermal Therapy. Nanoscale 10 (35), 16765–16774. doi:10.1039/c8nr04870c
Li, Z., Liu, J., Hu, Y., Howard, K. A., Li, Z., Fan, X., et al. (2016). Multimodal Imaging-Guided Antitumor Photothermal Therapy and Drug Delivery Using Bismuth Selenide Spherical Sponge. ACS Nano 10 (10), 9646–9658. doi:10.1021/acsnano.6b05427
Liu, T., Wang, C., Gu, X., Gong, H., Cheng, L., Shi, X., et al. (2014). Drug Delivery with PEGylated MoS2 Nano-Sheets for Combined Photothermal and Chemotherapy of Cancer. Adv. Mater. 26 (21), 3433–3440. doi:10.1002/adma.201305256
Liu, Y., Bhattarai, P., Dai, Z., and Chen, X. (2019). Photothermal Therapy and Photoacoustic Imaging via Nanotheranostics in Fighting Cancer. Chem. Soc. Rev. 48 (7), 2053–2108. doi:10.1039/c8cs00618k
Meng, X., Zhang, B., Yi, Y., Cheng, H., Wang, B., Liu, Y., et al. (2020). Accurate and Real-Time Temperature Monitoring during MR Imaging Guided PTT. Nano Lett. 20 (4), 2522–2529. doi:10.1021/acs.nanolett.9b05267
Ortega-Liebana, M. C., Encabo-Berzosa, M. M., Casanova, A., Pereboom, M. D., Alda, J. O., Hueso, J. L., et al. (2019). Upconverting Carbon Nanodots from Ethylenediaminetetraacetic Acid (EDTA) as Near-Infrared Activated Phototheranostic Agents. Chemistry 25 (21), 5539–5546. doi:10.1002/chem.201806307
Song, G., Liang, C., Gong, H., Li, M., Zheng, X., Cheng, L., et al. (2015). Core-Shell MnSe@Bi2Se3Fabricated via a Cation Exchange Method as Novel Nanotheranostics for Multimodal Imaging and Synergistic Thermoradiotherapy. Adv. Mater. 27 (40), 6110–6117. doi:10.1002/adma.201503006
Tang, S., Chen, M., and Zheng, N. (2015). Multifunctional Ultrasmall Pd Nanosheets for Enhanced Near-Infrared Photothermal Therapy and Chemotherapy of Cancer. Nano Res. 8 (1), 165–174. doi:10.1007/s12274-014-0605-x
Wang, Y., Zhao, J. X., Chen, Z., Zhang, F., Wang, Q., Guo, W., et al. (2019). Construct of MoSe2/Bi2Se3 Nanoheterostructure: Multimodal CT/PT Imaging-Guided PTT/PDT/Chemotherapy for Cancer Treating. Biomaterials 217, 13. doi:10.1016/j.biomaterials.2019.119282
Xiao, L., Zhu, A., Xu, Q., Chen, Y., Xu, J., and Weng, J. (2017). Colorimetric Biosensor for Detection of Cancer Biomarker by Au Nanoparticle-Decorated Bi2Se3 Nanosheets. ACS Appl. Mater. Inter. 9 (8), 6931–6940. doi:10.1021/acsami.6b15750
Xie, H., Shao, J., Wang, J., Sun, Z., Yu, X.-F., and Wang, Q.-Q. (2017). Near-infrared Optical Performances of Two Bi2Se3nanosheets. RSC Adv. 7 (79), 50234–50238. doi:10.1039/c7ra09872c
Yang, W., Guo, W., Le, W., Lv, G., Zhang, F., Shi, L., et al. (2016). Albumin-bioinspired Gd:CuS Nanotheranostic Agent for In Vivo Photoacoustic/Magnetic Resonance Imaging-Guided Tumor-Targeted Photothermal Therapy. ACS Nano 10 (11), 10245–10257. doi:10.1021/acsnano.6b05760
Yin, Z., Zhang, W., Fu, Q., Yue, H., Wei, W., Tang, P., et al. (2014). Construction of Stable Chainlike Au Nanostructures via Silica Coating and Exploration for Potential Photothermal Therapy. Small 10 (18), 3619–3624. doi:10.1002/smll.201400474
You, Q., Sun, Q., Wang, J., Tan, X., Pang, X., Liu, L., et al. (2017). A Single-Light Triggered and Dual-Imaging Guided Multifunctional Platform for Combined Photothermal and Photodynamic Therapy Based on TD-Controlled and ICG-Loaded CuS@mSiO2. Nanoscale 9 (11), 3784–3796. doi:10.1039/c6nr09042g
Zhang, H., Wang, Y., Zhong, H., Li, J., and Ding, C. (2019). Near-infrared Light-Activated Pt@Au Nanorings-Based Probe for Fluorescence Imaging and Targeted Photothermal Therapy of Cancer Cells. ACS Appl. Bio Mater. 2 (11), 5012–5020. doi:10.1021/acsabm.9b00712
Zhang, L., Qin, Y., Zhang, Z., Fan, F., Huang, C., Lu, L., et al. (2018). Dual pH/Reduction-Responsive Hybrid Polymeric Micelles for Targeted Chemo-Photothermal Combination Therapy. Acta Biomater. 75, 371–385. doi:10.1016/j.actbio.2018.05.026
Zhao, S., Tian, R., Shao, B., Feng, Y., Yuan, S., Dong, L., et al. (2020). UCNP-bi 2 Se 3 Upconverting Nanohybrid for Upconversion Luminescence and CT Imaging and Photothermal Therapy. Chem. Eur. J. 26, 1127–1135. doi:10.1002/chem.201904586
Keywords: photothermal therapy, Bi2Se3 nanodots, ultrafast synthesis, CT imaging, cancer therapy
Citation: Zhang P, Wang L, Chen X, Li X and Yuan Q (2021) Ultrasmall PEI-Decorated Bi2Se3 Nanodots as a Multifunctional Theranostic Nanoplatform for in vivo CT Imaging-Guided Cancer Photothermal Therapy. Front. Pharmacol. 12:795012. doi: 10.3389/fphar.2021.795012
Received: 14 October 2021; Accepted: 16 November 2021;
Published: 02 December 2021.
Edited by:
Kelong Ai, Central South University, ChinaReviewed by:
Dan Li, The Fifth Affiliated Hospital of Sun Yat-sen University, ChinaJing Wang, Huazhong University of Science and Technology, China
Copyright © 2021 Zhang, Wang, Chen, Li and Yuan. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Qinghai Yuan, yuanqinghai123@sina.com